Merit Medical Systems INC Form 4 insider transactions

Neil Peterson, Chief Operating Officer of Merit Medical Systems, reports the acquisition of 7,319 restricted stock units (RSUs) on March 4, 2024.

Chief Commercial Officer Joseph Wright reports acquisition and disposal of Merit Medical Systems stock, including grants of restricted stock units and shares acquired from performance stock units.

Brian G. Lloyd, Chief Legal Officer and Secretary of Merit Medical Systems Inc., reports acquisition of restricted stock units and performance stock units, as well as shares surrendered for tax obligations.

CEO Fred Lampropoulos reports acquisition and disposal of Merit Medical Systems Inc. stock, including grants of restricted stock units and performance stock units.

CFO Raul Parra Jr. reports acquisition and disposal of Merit Medical Systems stock, including grants of restricted stock units and performance stock units, as well as shares surrendered for tax obligations.

Director Thomas James Gunderson reports the acquisition and disposition of Merit Medical Systems (MMSI) stock and stock options.

Stephen C. Evans, a director at Merit Medical Systems, sold 1,000 shares of common stock at an average price of $76.348 on March 4, 2024.